Dehydration promotes intracellular lipid synthesis and accumulation
Joshua Carty(Tennessee Oncology), Juan Pablo Arroyo(Vanderbilt University), John T. Tossberg(Tennessee Oncology), Ryoichi Bessho(Asahikawa Medical University), Clothilde Pénalva(University of Utah), Jamey D. Young(Vanderbilt University), Irene Chernova(Yale University), Olga M. Viquez(Tennessee Oncology), John A. McLean(Vanderbilt University), José Pablo Vázquez‐Medina(University of California, Berkeley), Shirong Cao(Vanderbilt University Medical Center), Katrina L. Leaptrot(Vanderbilt University), Jean‐Philippe Cartailler(Vanderbilt Health), Roy Zent(Vanderbilt University), Fabian Bock(Tennessee Oncology), Raymond C. Harris(Vanderbilt University Medical Center), Wei Sheng Yap(University of Toronto), Clinton M. Hasenour(Vanderbilt University), Meiling Melzer(Tennessee Oncology), Matthew A. Cottam(Vanderbilt University), Alexandra C. Schrimpe‐Rutledge(Pacific Northwest National Laboratory), Andrew S. Terker(Vanderbilt University Medical Center), A. Scott McCall(Vanderbilt University Medical Center), Jeffrey C. Rathmell(University of Chicago), Deepti Shrivastava(Saveetha University), Yvonne Zuchowski(Tennessee Oncology), Stacy D. Sherrod(Vanderbilt University), Jason A. Watts(National Institute of Environmental Health Sciences), Simona G. Codreanu(Vanderbilt University), Dylan K. Kosma(University of Nevada, Reno), Volker H. Haase(Vanderbilt University Medical Center), Erin Q. Jennings(Vanderbilt University Medical Center), Matthew H. Wilson(Vanderbilt University), Aylin R. Rodan(University of Utah), Louise Lantier(Vanderbilt University), Kelsey Voss(University of Virginia), Jazlyn A. Selvasingh(Tennessee Oncology), Mingzhi Zhang(First Affiliated Hospital of Zhengzhou University), Peter Kim(Sanofi (United States)), Ma Wan(Zhejiang A & F University), Hyuck-Jin Nam(University of Utah), Elizabeth Piotrowski(University of California, Berkeley), Gayani Nanayakkara(Fox Chase Cancer Center), Jonathan B. Trapani(Tennessee Oncology), Edith T. Adame(Tennessee Oncology), Don A. Delker(National Institutes of Health)
Cited by 1
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Lactate Metabolism in Human Lung Tumors
|Cell|2017|1.3k
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717